Adam Kibel(@adamkibel_uro) 's Twitter Profileg
Adam Kibel

@adamkibel_uro

Chief of Urology at Brigham & Women’s, Surgical Oncologist, Runner, Golfer, Skier

ID:1528153221415436289

calendar_today21-05-2022 23:18:26

110 Tweets

498 Followers

223 Following

Adam Kibel(@adamkibel_uro) 's Twitter Profile Photo

Urology's Inconvenient Truth: Impact of Climate Change - Food for thought. Need to address waste and improve the environment. ⁦Alexander P Cole⁩ ⁦Brigham and Women's Hospital Department of Urology⁩ medscape.com/viewarticle/ur…

account_circle
European Association of Urology (EAU)(@Uroweb) 's Twitter Profile Photo

Prostate cancer cases worldwide likely to double by 2040, analysis finds.

Largest study of its kind predicts 85% increase in deaths from the disease in same period as more men live longer.



theguardian.com/society/2024/a…

account_circle
Adam Kibel(@adamkibel_uro) 's Twitter Profile Photo

EAU24 data. Checkmate 274 survival advantage for adjuvant NIVO. The treatment of bladder cancer continues to improve! Wonderful.

EAU24 data. Checkmate 274 survival advantage for adjuvant NIVO. The treatment of bladder cancer continues to improve! Wonderful.
account_circle
Adam Kibel(@adamkibel_uro) 's Twitter Profile Photo

Wonderful presentation. Improved communication leads to better outcomes. Cure and quality of life. Thanks for pushing this important aspect of care.

account_circle
Adam Kibel(@adamkibel_uro) 's Twitter Profile Photo

Wonderful visit by Dr. Stakhovsky. Learned about the difficulties in delivering cancer care in Ukraine. He is doing wonderful work in difficult times.

account_circle
Adam Kibel(@adamkibel_uro) 's Twitter Profile Photo

Good randomized trial showing no difference between TP and TR biopsies. We need data to prove TP better before whole sale adoption. ⁦⁦Albany Med Health System⁩ ⁦Brigham and Women's Hospital Department of Urology⁩ health.harvard.edu/blog/new-resea…

account_circle
#TumorBoardTuesday(@TumorBoardTues) 's Twitter Profile Photo

🧵1/8 brought early holiday 🎁!

Enfortumab vedotin + pembro nearly DOUBLES OS vs chemo in 1L advanced
Addition of IO to chemo ALSO ⬆️ outcomes

Jon Anker, MD, PhD & Matt Galsky took us how practice is changing. Read on for the case wrap up! 👇

🧵1/8 #ESMO23 brought early holiday 🎁! Enfortumab vedotin + pembro nearly DOUBLES OS vs chemo in 1L advanced #bladdercancer Addition of IO to chemo ALSO ⬆️ outcomes @JonAnker1 & @MattGalsky took us how practice is changing. Read on for the #TumorBoardTuesday case wrap up! 👇
account_circle
Adam Kibel(@adamkibel_uro) 's Twitter Profile Photo

Yes. Surgery should be in the discussion. But harder to get all the LN. Key is if the LN can be reliably identified and removed. They are often out of the primary landing zone. Perirectal for example.

account_circle